Skip to content

Intramuscular Ketamine to Treat Major Depressive Disorder: A Case Series of Forty Patients

Journal of Psychiatry and Mental Health 2021 DOI: 10.16966/2474-7769.145 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case report Peer reviewed
Topics Depression Esketamine Ketamine
Citations 7

Abstract

Introduction: While the use of ketamine to treat severe depression and post-traumatic stress disorder has been well documented in the literature, fewer studies have investigated the efficacy of Intramuscular (IM) ketamine to treat these conditions.

Explore topics

By condition and practice